Skip to content

Nephrotic Syndrome Type 3 C1853124

Published: July 22, 2026Updated: August 20, 2026

A kidney condition marked by excessive protein in urine and related symptoms, with genetic factors involved.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q63.9
ICD-11
LA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Acute kidney injury (oliguria)

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Nephrotic-range proteinuria

(renal)

Facial and periorbital edema

(renal)

Dyslipidemia (elevated LDL/VLDL)

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Calcineurin inhibitors

Calcineurin inhibitors like tacrolimus or cyclosporine may be used when corticosteroids are ineffective or contraindicated. Requires therapeutic drug monitoring.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Corticosteroid therapy

Systemic corticosteroids remain a cornerstone treatment to induce remission and control glomerular inflammation. Duration depends on response.

medication

Additional treatment options

Protein intake management

Moderate protein restriction with adequate caloric intake helps manage proteinuria while preventing malnutrition. Individualized dietary plans are recommended.

dietary

Statin therapy

Lipid-lowering agents are used to address hyperlipidemia common in nephrotic syndrome, reducing cardiovascular risk.

medication

Renal function surveillance

Regular assessment of kidney function through serum creatinine and estimated glomerular filtration rate helps detect progression early.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Nephrotic Syndrome Type 3 C1853124?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Nephrotic Syndrome Type 3 C1853124. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy